Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 393

1.

Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients.

Kawai Y, Miyashita N, Yamaguchi T, Saitoh A, Kondoh E, Fujimoto H, Teranishi H, Inoue M, Wakabayashi T, Akaike H, Ogita S, Kawasaki K, Terada K, Kishi F, Ouchi K.

Respirology. 2012 Feb;17(2):354-62. doi: 10.1111/j.1440-1843.2011.02102.x.

PMID:
22077195
2.

Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients.

Kawai Y, Miyashita N, Kubo M, Akaike H, Kato A, Nishizawa Y, Saito A, Kondo E, Teranishi H, Ogita S, Tanaka T, Kawasaki K, Nakano T, Terada K, Ouchi K.

Antimicrob Agents Chemother. 2013 May;57(5):2252-8. doi: 10.1128/AAC.00048-13. Epub 2013 Mar 4.

3.

Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia.

Miyashita N, Kawai Y, Akaike H, Ouchi K, Hayashi T, Kurihara T, Okimoto N; Atypical Pathogen Study Group.

BMC Infect Dis. 2012 May 31;12:126. doi: 10.1186/1471-2334-12-126.

4.

More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia.

Zhou Y, Zhang Y, Sheng Y, Zhang L, Shen Z, Chen Z.

Antimicrob Agents Chemother. 2014;58(2):1034-8. doi: 10.1128/AAC.01806-13. Epub 2013 Nov 25.

5.

Characterization of macrolide resistance of Mycoplasma pneumoniae in children in Shenzhen, China.

Ma Z, Zheng Y, Deng J, Ma X, Liu H.

Pediatr Pulmonol. 2014 Jul;49(7):695-700. doi: 10.1002/ppul.22851. Epub 2013 Jul 17.

PMID:
23861188
6.

High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China.

Cao B, Zhao CJ, Yin YD, Zhao F, Song SF, Bai L, Zhang JZ, Liu YM, Zhang YY, Wang H, Wang C.

Clin Infect Dis. 2010 Jul 15;51(2):189-94. doi: 10.1086/653535.

PMID:
20540621
7.

Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.

Li X, Atkinson TP, Hagood J, Makris C, Duffy LB, Waites KB.

Pediatr Infect Dis J. 2009 Aug;28(8):693-6. doi: 10.1097/INF.0b013e31819e3f7a.

PMID:
19633515
8.

Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis.

Wolff BJ, Thacker WL, Schwartz SB, Winchell JM.

Antimicrob Agents Chemother. 2008 Oct;52(10):3542-9. doi: 10.1128/AAC.00582-08. Epub 2008 Jul 21.

9.

Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany.

Dumke R, von Baum H, Lück PC, Jacobs E.

Clin Microbiol Infect. 2010 Jun;16(6):613-6. doi: 10.1111/j.1469-0691.2009.02968.x. Epub 2009 Sep 17.

10.

Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis.

Peuchant O, Ménard A, Renaudin H, Morozumi M, Ubukata K, Bébéar CM, Pereyre S.

J Antimicrob Chemother. 2009 Jul;64(1):52-8. doi: 10.1093/jac/dkp160. Epub 2009 May 9.

PMID:
19429926
11.

Macrolide-resistant Mycoplasma pneumoniae in children in Taiwan.

Wu HM, Wong KS, Huang YC, Lai SH, Tsao KC, Lin YJ, Lin TY.

J Infect Chemother. 2013 Aug;19(4):782-6. doi: 10.1007/s10156-012-0523-3. Epub 2012 Nov 30.

PMID:
23196653
12.

Nested PCR-linked capillary electrophoresis and single-strand conformation polymorphisms for detection of macrolide-resistant Mycoplasma pneumoniae in Beijing, China.

Lin C, Li S, Sun H, Zhao H, Feng Y, Cao L, Yuan Y, Zhang T.

J Clin Microbiol. 2010 Dec;48(12):4567-72. doi: 10.1128/JCM.00400-10. Epub 2010 Sep 22.

13.

Community outbreak of macrolide-resistant Mycoplasma pneumoniae in Yamagata, Japan in 2009.

Suzuki Y, Itagaki T, Seto J, Kaneko A, Abiko C, Mizuta K, Matsuzaki Y.

Pediatr Infect Dis J. 2013 Mar;32(3):237-40. doi: 10.1097/INF.0b013e31827aa7bd.

PMID:
23114374
14.

Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children.

Okada T, Morozumi M, Tajima T, Hasegawa M, Sakata H, Ohnari S, Chiba N, Iwata S, Ubukata K.

Clin Infect Dis. 2012 Dec;55(12):1642-9. doi: 10.1093/cid/cis784. Epub 2012 Sep 12.

PMID:
22972867
15.

Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010.

Averbuch D, Hidalgo-Grass C, Moses AE, Engelhard D, Nir-Paz R.

Emerg Infect Dis. 2011 Jun;17(6):1079-82. doi: 10.3201/eid/1706.101558.

16.

Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan.

Matsuda K, Narita M, Sera N, Maeda E, Yoshitomi H, Ohya H, Araki Y, Kakuma T, Fukuoh A, Matsumoto K.

BMC Infect Dis. 2013 Dec 16;13:591. doi: 10.1186/1471-2334-13-591.

17.
18.
19.

Rapid detection of Mycoplasma pneumoniae and its macrolide-resistance mutation by Cycleave PCR.

Liu Y, Ye X, Zhang H, Wu Z, Xu X.

Diagn Microbiol Infect Dis. 2014 Apr;78(4):333-7. doi: 10.1016/j.diagmicrobio.2013.12.002. Epub 2013 Dec 13.

PMID:
24503503
20.

[The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children].

Bao F, Qu JX, Liu ZJ, Qin XG, Cao B.

Zhonghua Jie He He Hu Xi Za Zhi. 2013 Oct;36(10):756-61. Chinese.

PMID:
24433804

Supplemental Content

Support Center